|
IPSC | Century Therapeutics, Inc. |
|
|
IPSC | Century Therapeutics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 1.16 |
| Leverage | 28.95% |
| Market Cap | $ 137.0m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -9.6m |
| Margin | -8.72% |
None